Where is MadeMed available?

Its injectable semaglutide page names 23 states: Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Maine, Missouri, Montana, North Dakota, New Mexico, New York, Rhode Island, South Dakota, Texas, Utah, Vermont, Wisconsin and Wyoming. That is a real enumerated list rather than a nationwide claim, which is worth crediting — and it is also under half the country, so check your state before anything else. Other products may carry a different list.

Does the price change as my dose goes up?

No, and MadeMed explains why in its own words: charging more at higher doses turns every titration conversation into a revenue decision for the prescriber, and it does not want its doctors near that math. The same price applies at 0.25 mg and at 2.4 mg. Dose increases are not automatic either — your dose holds until you say you are ready, and a step up is typically approved no sooner than every four weeks.

Can I switch to MadeMed without restarting my titration?

MadeMed says yes. Share your current dose and how long you have been on it during the consult — a recent prescription label or pharmacy invoice helps but is not required — and a physician can continue you at that dose rather than sending you back to 0.25 mg. It says most switchers go from consult to delivered medication in five to seven business days, with priority if you are running low.

How does MadeMed's billing work?

Subscriptions run monthly, quarterly, twice-yearly or yearly, with quarterly preselected, so check the cadence at checkout. MadeMed says it emails you seven days before every charge with the exact amount and links to pause, skip or cancel, that cancellation is one click from the dashboard with no phone call, and that pausing stops billing immediately rather than at the end of the cycle. Those three policies together are the cleanest subscription terms on this board.

What does MadeMed offer besides GLP-1?

Injectable and oral sermorelin, NAD⁺ as an injection or a nasal spray, and tadalafil for sexual health, all under the same account. The GLP-1s rest on large published trials; the sermorelin and NAD⁺ lines do not have comparable controlled human-outcome data, so price and judge them separately rather than as part of the same decision.

MadeMed is a GLP-1 telehealth service you reach through an online intake a clinician reviews. The medications it names are Semaglutide and Tirzepatide. Its stated availability: Injectable semaglutide listed in 23 named states. What it publishes up front: One-account telehealth (GLP-1 + longevity). It is cash-pay and states it does not bill insurance. What our record does not establish: a single monthly price you can check before an intake. Ask for those in writing before you pay.

PartnerUpdated August 2026

MadeMed review

Flat dosing, narrow footprint

One flat price at every dose, an argument for why that matters, and a state list of 23 — the smallest published footprint on this board.

Our verdict

MadeMed has thought harder about the incentive under the price than anyone else here. Its own FAQ says the reason it charges one flat rate at every dose is that most telehealth services charge more as you titrate, which turns each dose increase into a revenue decision the prescriber is standing next to. That is an unusually clear-eyed thing for a seller to write about its own category, and the policy backs it up: the same price at 0.25 mg and at 2.4 mg, dose increases never automatic and never sooner than every four weeks, a seven-day warning email before every charge, and cancellation in one click. The catch is geography. Its injectable semaglutide page names 23 states, which is under half the country and the narrowest published footprint on this board.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →One-account telehealth (GLP-1 + longevity)

At a glance

Category: GLP-1 telehealth
Access: One-account telehealth (GLP-1 + longevity)
Medications: Semaglutide · Tirzepatide
Insurance: Cash-pay, no insurance
Visit: Async intake
Availability: Injectable semaglutide listed in 23 named states
Updated: August 2026

What it is

A cash-pay telehealth service running four weight-loss products — injectable and oral semaglutide, injectable and oral tirzepatide — alongside sermorelin in injectable and oral form, NAD⁺ as an injection and a nasal spray, and tadalafil for sexual health. It describes itself as connecting patients to board-certified physicians and licensed pharmacies, and states LegitScript certification, which we record as the company's claim. Subscriptions run monthly, quarterly, twice-yearly or yearly, with quarterly as the default selection, so check which cadence your checkout has chosen for you before you agree to it.

How it works

An online consultation, review by a MadeMed physician, and overnight shipping in temperature-controlled packaging with syringes, alcohol swabs and injection supplies included at no extra cost. The subscription mechanics are where the service is unusually patient-friendly, and each one is stated as policy rather than implied. You are emailed seven days before every charge with the exact amount and the option to pause, skip or cancel. Canceling is one click from the dashboard with no phone call and no retention queue. Pausing stops billing immediately rather than at the end of the cycle. Support is offered by phone, email or chat, with the service saying explicitly that it does not route you to an AI chatbot. Optional meal plans, recipes, shopping lists and exercise programs are included at no extra charge. It also handles transfers deliberately: if you are already on a GLP-1 elsewhere, MadeMed says you do not need to restart titration — share a recent prescription label or invoice and a physician can continue you at your current dose, typically with medication delivered within five to seven business days.

Pricing transparency

MadeMed does not publish a figure on its open pages; the number appears once you select a product, a dose and a plan length. What it does publish is the pricing structure, which matters more than most headline rates. One flat price applies at every dose from 0.25 mg to 2.4 mg, so titrating up never raises the bill — and MadeMed states the reasoning outright: charging more at higher doses puts the prescriber on the wrong side of the patient's treatment. It also includes L-carnitine with every semaglutide dose at no extra charge, and free overnight shipping with all injection supplies. Plan cadences are monthly, quarterly, twice-yearly and yearly, with quarterly preselected. Insurance does not cover compounded medication, which MadeMed says plainly rather than implying coverage, and it compares its price against a stated $1,000 to $1,400 a month for brand-name out of pocket.

Branded vs compounded

Four GLP-1 products — semaglutide and tirzepatide, each as a weekly injection or an oral form — plus injectable and oral sermorelin, NAD⁺ by injection or nasal spray, and tadalafil. The semaglutide dose ladder is published rather than left to the funnel: 0.25 mg for roughly four weeks to build tolerance, then 0.5, 1, 1.7 and up to 2.4 mg, with the service noting that most patients stabilize at 1 mg and only about a fifth need more. Its eligibility criteria and exclusions are stated too — a BMI of 30 or more, or 27 with a weight-related condition, and not appropriate with a personal or family history of medullary thyroid cancer, MEN 2, or in pregnancy or breastfeeding. It also answers the question most services avoid: weight regain after stopping is common, appetite returns to baseline, and some patients stay on a maintenance dose. Compounded preparations are not FDA-approved and are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound. The sermorelin and NAD⁺ lines carry far less human-outcome evidence than the two GLP-1s and belong in a separate column of your reasoning.

Pros and watch-outs

What we like

One flat price at every dose from 0.25 mg to 2.4 mg, with the incentive argument for it stated in its own FAQ
Dose increases are never automatic and typically no sooner than every four weeks, with the patient initiating
A seven-day warning email before every charge, naming the exact amount, with pause, skip and cancel options
Cancel in one click from the dashboard; pausing stops billing immediately rather than at the next cycle
Publishes an enumerated 23-state list for injectable semaglutide rather than claiming vague nationwide coverage
Publishes the full dose ladder, the eligibility criteria and the exclusions
Says weight regain after stopping is common instead of leaving it out
L-carnitine included with every semaglutide dose, and free overnight temperature-controlled shipping with all supplies
Continues switchers at their existing dose rather than forcing a restart of titration
Human support by phone, email or chat, with an explicit commitment not to route you to a chatbot

Watch-outs

Availability is the narrowest here — 23 named states for injectable semaglutide, under half the country
No price appears on the open site; the figure surfaces only after you choose a product, dose and plan
Quarterly billing is preselected, so a monthly cadence has to be chosen deliberately
No pharmacy is named on the public pages
Insurance does not cover the compounded medication, which MadeMed states rather than works around
Compounded only — no FDA-approved branded option
Sermorelin and NAD⁺ are sold beside the GLP-1s without the evidence gap being flagged

Best for

People in one of its 23 states who want the price to stay flat as the dose climbs, clean subscription mechanics, and a transfer that does not restart titration.

Who should look elsewhere

Anyone outside its published states, anyone who wants to compare prices before entering a funnel, or anyone who needs branded medication or insurance billing.

The evidence behind what MadeMed prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Oral semaglutide (Rybelsus): what the PIONEER trials actually showed
A GLP-1 peptide in a pill is hard to pull off. PIONEER 1, 4, and 6 plus OASIS 1 — read straight from the primary literature.
Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
NAD⁺ nasal spray: the delivery format with the least direct evidence
Intranasal NAD⁺ is convenient and heavily marketed — but no controlled human trial shows the spray raises systemic or brain NAD⁺. A straight comparison with the better-studied routes.

How MadeMed compares

A few alternatives worth a look, depending on what you’re optimizing for.

Shed
The widest range of GLP-1 formats (injection, drops, lozenges, microdose)
See Shed →
Live Vital
Pairing a GLP-1 with a wider peptide and longevity protocol
See Live Vital →
Telos RX
Choice of GLP-1 formats, including needle-free sublingual tirzepatide
See Telos RX →

Compare all providers side by side →

More GLP-1 telehealth reviews: Lighter YouAHBARxAlinwellAndrew MedsBayan HealthBelieve Health

Nadia Feldman

Access & cost · Reviewed and last verified August 2026

How we assessed this. This review reflects Aminoscope’s own read of MadeMed’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Where is MadeMed available?: Its injectable semaglutide page names 23 states: Arizona, Colorado, Connecticut, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Maine, Missouri, Montana, North Dakota, New Mexico, New York, Rhode Island, South Dakota, Texas, Utah, Vermont, Wisconsin and Wyoming. That is a real enumerated list rather than a nationwide claim, which is worth crediting — and it is also under half the country, so check your state before anything else. Other products may carry a different list.
Does the price change as my dose goes up?: No, and MadeMed explains why in its own words: charging more at higher doses turns every titration conversation into a revenue decision for the prescriber, and it does not want its doctors near that math. The same price applies at 0.25 mg and at 2.4 mg. Dose increases are not automatic either — your dose holds until you say you are ready, and a step up is typically approved no sooner than every four weeks.
Can I switch to MadeMed without restarting my titration?: MadeMed says yes. Share your current dose and how long you have been on it during the consult — a recent prescription label or pharmacy invoice helps but is not required — and a physician can continue you at that dose rather than sending you back to 0.25 mg. It says most switchers go from consult to delivered medication in five to seven business days, with priority if you are running low.
How does MadeMed's billing work?: Subscriptions run monthly, quarterly, twice-yearly or yearly, with quarterly preselected, so check the cadence at checkout. MadeMed says it emails you seven days before every charge with the exact amount and links to pause, skip or cancel, that cancellation is one click from the dashboard with no phone call, and that pausing stops billing immediately rather than at the end of the cycle. Those three policies together are the cleanest subscription terms on this board.
What does MadeMed offer besides GLP-1?: Injectable and oral sermorelin, NAD⁺ as an injection or a nasal spray, and tadalafil for sexual health, all under the same account. The GLP-1s rest on large published trials; the sermorelin and NAD⁺ lines do not have comparable controlled human-outcome data, so price and judge them separately rather than as part of the same decision.
Is MadeMed legit?: MadeMed is a GLP-1 telehealth service you reach through an online intake a clinician reviews. The medications it names are Semaglutide and Tirzepatide. Its stated availability: Injectable semaglutide listed in 23 named states. What it publishes up front: One-account telehealth (GLP-1 + longevity). It is cash-pay and states it does not bill insurance. What our record does not establish: a single monthly price you can check before an intake. Ask for those in writing before you pay.

Check availability →

Or compare every GLP-1 provider.